Health Services Access Inequalities in Brazil Result in Poorer Outcomes for Stage III NSCLC—RELANCE/LACOG 0118

Introduction: Stage III NSCLC is a heterogeneous disease, representing approximately one-third of newly diagnosed lung cancers. Brazil lacks detailed information regarding stage distribution, treatment patterns, survival, and prognostic variables in locally advanced NSCLC. Methods: RELANCE/LACOG 011...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Vladmir C. Cordeiro de Lima, MD, PhD, Ana Gelatti, MD, MSc, José F.P. Moura, MD, PhD, Aline F. Fares, MD, MSc, Gilberto de Castro, Jr., MD, PhD, Clarissa Mathias, MD, PhD, Ricardo M. Terra, MD, PhD, Gustavo Werutsky, MD, PhD, Marcelo Corassa, MD, Luiz Henrique L. Araújo, MD, PhD, Eduardo Cronenberger, MD, MSc, Fernanda K. Fujiki, MD, Sandro Reichow, MD, Antônio Vinícius T. da Silva, MD, Tércia V. Reis, MD, Mônica Luciana A. Padoan, MD, Patrícia Pacheco, MD, Rosely Yamamura, MD, Caroline Kawamura, MD, Eldsamira Mascarenhas, MD, MSc, Rafaela G. de Jesus, MSc, Gustavo Gössling, MD, Clarissa Baldotto, MD, PhD
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Elsevier 2024-03-01
Σειρά:	JTO Clinical and Research Reports
Θέματα:	NSCLC Epidemiology Stage III Health insurance Survival
Διαθέσιμο Online:	http://www.sciencedirect.com/science/article/pii/S266636432400016X
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!